Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: a study based on coronary angiography

被引:45
作者
Goto, A
Sasai, K
Suzuki, S
Fukutomi, T
Ito, S
Matsushita, T
Okamoto, M
Suzuki, T
Itoh, M
Okumura-Noji, K
Yokoyama, S
机构
[1] Nagoya City Univ, Sch Med, Nagoya, Aichi 4678601, Japan
[2] Owari Prefectural Hosp, Ctr Cardiovasc, Ichinomiya, Aichi 4910934, Japan
[3] Toyohashi Higashi Natl Hosp, Dept Cardiol, Toyohashi, Aichi 4408510, Japan
关键词
CETP; HDL; LDL; coronary heart disease; atherosclerosis; gene polymorphism;
D O I
10.1016/S0021-9150(01)00476-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We undertook a cross-sectional analysis on CETP and atherosclerosis among Japanese subjects, by means of CETP mass assay, its gene polymorphism and coronary angiogram. The 110 consecutive patients who underwent coronary angiography were enrolled into the study except for those over 70 years and taking lipid-lowering drugs. Association was analyzed among plasma lipid and lipoproteins, CETP mass, its gene polymorphisms and the finding in coronary angiography. Four CETP-deficiency heterozygotes were identified and excluded from the analysis. CETP mass level showed neither significant correlation with the coronary score (CS) (r = 0.06, P = 0.52) nor the difference between the groups eventually diagnosed as coronary heart disease (CHD) positive and CHD negative (2.36 +/- 0.57 vs. 2.24 +/- 0.21, P = 0.24). CETP mass correlated with the total and LDL cholesterol (r = 0.43, P < 0.001; r = 0,36, P < 0.001, respectively) but not with HDL cholesterol (r = 0.08, P = 0.40). While 1405V polymorphism had no impact on CETP mass, HDL cholesterol or CS, CETP mass was low with TaqIB polymorphism (B1B1 > B2B2, P < 0.05) only in the low CS group ( < 4). Among the lipid and lipoprotein, HDL cholesterol had a greater impact than LDL cholesterol on coronary atherosclerosis. We concluded that CETP mass in plasma does not correlate with coronary atherosclerosis as whole in the non-CETP-deficient. However, the B2B2 genotype in CETP TaqIB polymorphism, only when it decreases the CETP level, may act as a protective factor against atherosclerosis. It should also be noted that CETP mass in general correlates to total and LDL cholesterol, so that it would be an indirect atherogenic parameter. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:153 / 163
页数:11
相关论文
共 60 条
[1]   Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene [J].
Agerholm-Larsen, B ;
Nordestgaard, BG ;
Steffensen, R ;
Jensen, G ;
Tybjærg-Hansen, A .
CIRCULATION, 2000, 101 (16) :1907-1912
[2]  
Austen W G, 1975, Circulation, V51, P5
[3]   CETP and atherosclerosis [J].
Barter, P .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (09) :2029-2031
[4]   INCREASED TRANSFER OF CHOLESTERYL ESTERS FROM HIGH-DENSITY-LIPOPROTEINS TO LOW-DENSITY AND VERY LOW-DENSITY LIPOPROTEINS IN PATIENTS WITH ANGIOGRAPHIC EVIDENCE OF CORONARY-ARTERY DISEASE [J].
BHATNAGAR, D ;
DURRINGTON, PN ;
CHANNON, KM ;
PRAIS, H ;
MACKNESS, MI .
ATHEROSCLEROSIS, 1993, 98 (01) :25-32
[5]  
Bruce C, 1998, J LIPID RES, V39, P1071
[6]   Plasma cholesteryl ester transfer protein is lowered by treatment of hypercholesterolemia with cholestyramine [J].
Carrilho, AJF ;
Medina, WL ;
Nakandakare, ER ;
Quintao, ECR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (01) :82-88
[7]   HDL CHOLESTEROL AND OTHER LIPIDS IN CORONARY HEART-DISEASE - COOPERATIVE LIPOPROTEIN PHENOTYPING STUDY [J].
CASTELLI, WP ;
DOYLE, JT ;
GORDON, T ;
HAMES, CG ;
HJORTLAND, MC ;
HULLEY, SB ;
KAGAN, A ;
ZUKEL, WJ .
CIRCULATION, 1977, 55 (05) :767-772
[8]   INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP ;
GARRISON, RJ ;
WILSON, PWF ;
ABBOTT, RD ;
KALOUSDIAN, S ;
KANNEL, WB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838
[9]  
CASTELLI WP, 1988, CAN J CARDIOL, V4, pA5
[10]   Cholesteryl ester transfer in hypercholesterolaemia: fasting and postprandial studies with and without pravastatin [J].
Contacos, C ;
Barter, PJ ;
Vrga, L ;
Sullivan, DR .
ATHEROSCLEROSIS, 1998, 141 (01) :87-98